Reports on sepsis therapy findings from Sichuan University provide new insights

2009 NOV 30 -- Research findings, 'Recombinant human growth hormone improves survival and protects against acute lung injury in murine Staphylococcus aureus sepsis,' are discussed in a new report. According to recent research from Chengdu, People's Republic of China, "To investigate whether recombinant human growth hormone (rhGH) reduces mortality and protects against Staphylococcus aureus sepsis-induced acute lung injury. The bacteria-positive rate of blood smears and bacteria colony counts in bacteria plate culture, TNF-alpha and IL-10 plasma levels, lung injury score, expression of intercellular adhesion molecule-1 (ICAM-1) as well as activation of nuclear...

In order to view the entire article, please read your options to the right